Dermapharm Holding SE
DUS:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dermapharm Holding SE
DUS:DMP
|
DE |
|
Consolidated Water Co Ltd
NASDAQ:CWCO
|
KY |
|
Goldwin Inc
TSE:8111
|
JP |
|
Sasol Ltd
OTC:SASOF
|
ZA |
|
D
|
Dermapharm Holding SE
XMUN:DMP
|
DE |
|
H
|
Harmony Gold Mining Company Ltd
DUS:HAM1
|
ZA |
|
O
|
Oceaneering International Inc
F:OII
|
US |
|
N
|
Netweb Technologies India Ltd
NSE:NETWEB
|
IN |
|
SBW
KRX:102280
|
KR |
|
Swire Pacific Ltd
HKEX:19
|
HK |
|
Carmax Inc
NYSE:KMX
|
US |
|
S
|
Sanmina Corp
XMUN:SAYN
|
US |
|
Resona Holdings Inc
TSE:8308
|
JP |
|
I
|
Idacorp Inc
XMUN:IDJ
|
US |
|
A
|
ADES Holding Company SJSC
SAU:2382
|
SA |
Wall St Price Targets
DMP Price Targets Summary
Dermapharm Holding SE
According to Wall Street analysts, the average 1-year price target for DMP is 50.46 EUR with a low forecast of 43.97 EUR and a high forecast of 62.33 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DMP's stock price target?
Price Target
50.46
EUR
According to Wall Street analysts, the average 1-year price target for DMP is 50.46 EUR with a low forecast of 43.97 EUR and a high forecast of 62.33 EUR.
What is the Revenue forecast for Dermapharm Holding SE?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for Dermapharm Holding SE?
Projected CAGR
4%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Dermapharm Holding SE?
Projected CAGR
6%
Over the last 10 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Dermapharm Holding SE?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 8%.
